SCHEMBL9516340

SCHEMBL9516340

CCC[C@H](N[C@H]1CCC2CCCC2N(CC(=O)O)C1=O)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACE P12821 12/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9516333 1.00 ACE (0.53) ACE
SCHEMBL9515265 1.00 ACE (0.53) ACE
SCHEMBL9518623 1.00 ACE (0.53) ACE
SCHEMBL9516452 1.00 ACE (0.53) ACE
SCHEMBL9515234 1.00 ACE (0.53) ACE
SCHEMBL9518555 1.00 ACE (0.53) ACE
SCHEMBL10477313 0.89 ACE (0.48) ACE
SCHEMBL9516456 0.89 ACE (0.48) ACE
SCHEMBL9515378 0.89 ACE (0.48) ACE
SCHEMBL9517444 0.89 ACE (0.48) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0279350-B1 Fused azepinone and azocinone derivatives , process for their preparation, agents containing them and their use, as well as their intermediates during their production HOECHST AG (DE) 1993-12-01 EP claimed
US-4857520-A Fused azepinone and azocinone derivatives, processes for their preparation, agents containing them and their use, and intermediates in their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-15 US claimed
EP-0279350-A2 Fused azepinone and azocinone derivatives , process for their preparation, agents containing them and their use, as well as their intermediates during their production HOECHST AKTIENGESELLSCHAFT (DE) 1988-08-24 EP claimed
EP-0279350-A2 Fused azepinone and azocinone derivatives , process for their preparation, agents containing them and their use, as well as their intermediates during their production HOECHST AKTIENGESELLSCHAFT (DE) 1988-08-24 EP disclosed